Momentus Inc. (MNTS) shares experienced a sharp decline in early trading Friday, dropping approximately 20% to around $13, following the company's announcement of a $25 million registered direct stock offering. The move, which involves the sale of newly issued shares to select institutional investors, is intended to bolster the company's cash reserves but simultaneously introduces significant dilution risk for existing shareholders.
Offering Details and Dilution Impact
The San Jose-based space infrastructure company disclosed an agreement to sell 1,851,852 shares of common stock to both new and existing long-term institutional investors. The offering is expected to close on or about June 15, subject to customary conditions. Net proceeds are earmarked for working capital and general corporate purposes. This type of registered direct offering allows the company to raise capital efficiently but reduces the ownership percentage of current shareholders, a factor that often weighs on stock sentiment.
Momentus had previously informed investors on June 8 that recent capital raises, warrant exercises, and use of its at-the-market program had strengthened its balance sheet to approximately $76 million in cash, cash equivalents, and short-term investments. The company also noted that its Vigoride 7 mission had transitioned into hosted payload operations.
Market Context and Sector Dynamics
The decline comes against a backdrop of heightened interest in space stocks, fueled by SpaceX's record-breaking IPO. Reuters reported that SpaceX priced a $75 billion IPO at $135 per share on June 11, valuing the company at roughly $1.77 trillion. This enthusiasm had previously lifted smaller space names like Momentus, but Friday's offering served as a stark reminder that balance-sheet improvements often come at the cost of shareholder dilution.
The broader market for space-related equities remains volatile, with investors weighing the potential of commercial space ventures against the financial realities of companies still in their growth phase.
Financial Health and Operational Milestones
Momentus's latest quarterly filing revealed that management no longer believes there is 'substantial doubt' about the company's ability to continue as a going concern, following financings completed since December 31, 2025. First-quarter service revenue rose to $3.2 million from $0.3 million a year earlier, driven by Vigoride 7 hosted payload services and expanded engineering project work for NASA and DARPA.
Despite these positive signs, the company remains unprofitable. The first-quarter net loss widened to $9.48 million from $6.17 million a year earlier, and operating cash used during the quarter was $5.8 million. Momentus also cautioned that it may require additional equity or debt financing if circumstances change, and failure to secure capital when needed could harm its business.
Catalysts Ahead: Vigoride 7 and Institutional Support
The next major catalyst for Momentus is the expected closing of the $25 million offering around June 15, followed by updates from the Vigoride 7 mission. The spacecraft launched to low Earth orbit on March 30 with 10 payloads, including those from DARPA, SpaceWERX, the U.S. Air Force Research Laboratory, NASA, and commercial customers. Successful mission execution could pave the way for future government and commercial contracts.
For investors, the key question is whether the infusion of new cash can translate into tangible mission execution and recurring revenue faster than dilution erodes potential upside. The stock remains highly speculative, with a rapidly changing share count and ongoing capital needs, making it a risky proposition despite the improved cash position.
